cancer

A 21st-century remedy for missed meds

Rice lab’s next-level encapsulation technology for drugs and vaccines could solve a $100 billion problem.

Upgraded tumor model optimizes search for cancer therapies

Rice U. bioengineers have developed an upgraded tumor model that houses bone cancer cells beside immune cells inside a 3D structure engineered to mimic bone and, through research using the model, found that the body’s immune response can make tumor cells more resistant to chemotherapy.

Lab Notes for Feb. 20, 2023

Rice joins neutrino megaproject. Engineering launches energy transition initiative. McHugh lands cancer research grant. Keck Foundation funds quantum research. West named Cottrell Scholar.

Rice scientists reengineer cancer drugs to be more versatile

Rice University scientists enlist widely used cancer therapy systems to control gene expression in mammalian cells, a feat of synthetic biology that could change how diseases are treated.

Naomi Halas named University Professor

Rice University has promoted nanotechnology pioneer Naomi Halas to its highest academic rank, University Professor. Halas, a 33-year member of Rice’s faculty, becomes only the 10th person and second woman to earn the title in Rice’s 111-year history.

DNA repair scheme gets closer look for cancer therapy

Rice bioscientists took a close look at one of the ways cells repair broken DNA and made a discovery about a promising target for cancer therapy.

Brain cancer research draws support

Bioengineer Kevin McHugh wins a Distinguished Scientist Award for brain cancer research from The Sontag Foundation.

Rice facility is ‘one-stop shop’ for customizing DNA to fight cancer

Rice bioengineers, synthetic biologists and cancer researchers celebrated the opening of Rice’s first CPRIT Core Facility, the Genetic Design and Engineering Center, or GDEC, Nov. 10 at the BRC.

Investors, leaders recognize 11 companies at annual Texas Life Science Forum

Life science innovators, academics and investors – including those specializing in health tech, medical devices and therapeutics – convened at Rice University this week to discuss Houston’s role in the future of health care and give awards to top early-stage life science companies.

‘Drug factory’ implants eliminate mesothelioma tumors in mice

Rice and Baylor researchers have used Rice’s “drug factory” implants to eradicate advanced-stage mesothelioma tumors in mice.

Rice, Baylor developing implants to heal heart attack injuries

Rice and Baylor College of Medicine are creating tiny implants that can heal damage from heart attacks.

Halas, Nordlander win prestigious Eni Energy Transition Award

Rice’s Naomi Halas and Peter Nordlander have won the prestigious 2022 Eni Energy Transition Award.

Rice lab’s ‘drug factory’ implants cleared for human trials

Federal regulators have approved the first human clinical trial of cancer-killing “drug factory” implants created by Rice bioengineers.

​​​​​​​Researchers discover new leukemia-killing compounds

Researchers from Rice and MD Anderson Cancer Center have discovered potential new drugs for treating leukemia.

CPRIT grants entice three cancer researchers to Rice

Rice University recruits three professors to bolster cancer research with grants from the Cancer Prevention and Research Institute of Texas.